Pandemic To Quicken Supply Shift From Mainland China, Benefit Taiwan R & D -- Amcham Taipei
Besides tension with the U.S., China ’s investment climate has become less appealing for some manufacturers due to rising costs
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Russell Flannery, Forbes Staff Source Type: news